Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Frampton, James E
696  Ergebnisse:
Personensuche X
?
1

Pemigatinib: A Review in Advanced Cholangiocarcinoma:

Frampton, James E.
Targeted Oncology.  19 (2024)  1 - p. 107-114 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Epcoritamab: First Approval:

Frampton, James E.
Drugs.  83 (2023)  14 - p. 1331-1340 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Inclisiran: A Review in Hypercholesterolemia:

Frampton, James E.
American Journal of Cardiovascular Drugs.  23 (2023)  2 - p. 219-230 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndrom..:

Frampton, James E.
Drugs.  83 (2023)  10 - p. 923-934 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Correction to: Fenfluramine: A Review in Dravet and Lennox-..:

Frampton, James E.
Drugs.  83 (2023)  12 - p. 1143-1143 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Ivosidenib: A Review in Advanced Cholangiocarcinoma:

Frampton, James E.
Targeted Oncology.  18 (2023)  6 - p. 973-980 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Osimertinib: A Review in Completely Resected, Early-Stage, ..:

Frampton, James E.
Targeted Oncology.  17 (2022)  3 - p. 369-376 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Darinaparsin: First Approval:

Frampton, James E.
Drugs.  82 (2022)  16 - p. 1603-1609 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Empagliflozin: A Review in Symptomatic Chronic Heart Failur:

Frampton, James E.
Drugs.  82 (2022)  16 - p. 1591-1602 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Teserpaturev/G47Δ: First Approval:

Frampton, James E.
BioDrugs.  36 (2022)  5 - p. 667-672 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Varenicline Solution Nasal Spray: A Review in Dry Eye Disea..:

Frampton, James E.
Drugs.  82 (2022)  14 - p. 1481-1488 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Correction to: Darinaparsin: First Approval:

Frampton, James E.
Drugs.  82 (2022)  16 - p. 1611-1611 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Isatuximab: A Review of Its Use in Multiple Myeloma:

Frampton, James E.
Targeted Oncology.  16 (2021)  5 - p. 675-686 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Correction to: Entrectinib: A Review in NTRK+ Solid Tumours..:

Frampton, James E.
Drugs.  81 (2021)  10 - p. 1239-1239 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCL:

Frampton, James E.
Drugs.  81 (2021)  6 - p. 697-708 , 2021
Link: https://doi.org/10.1007/..
 
1-15